VRCI vs. GENI, ABDX, PRM, LLAI, AGL, OBI, ONC, OPTI, SBTX, and TLY
Should you be buying Verici Dx stock or one of its competitors? The main competitors of Verici Dx include GENinCode (GENI), Abingdon Health (ABDX), Proteome Sciences (PRM), LungLife AI (LLAI), ANGLE (AGL), Ondine Biomedical (OBI), Oncimmune (ONC), OptiBiotix Health (OPTI), SkinBioTherapeutics (SBTX), and Totally (TLY). These companies are all part of the "medical" sector.
GENinCode (LON:GENI) and Verici Dx (LON:VRCI) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, institutional ownership, media sentiment, profitability, dividends, risk, analyst recommendations and community ranking.
41.6% of GENinCode shares are owned by institutional investors. Comparatively, 47.4% of Verici Dx shares are owned by institutional investors. 29.5% of GENinCode shares are owned by company insiders. Comparatively, 17.1% of Verici Dx shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
In the previous week, GENinCode and GENinCode both had 1 articles in the media. Verici Dx's average media sentiment score of 0.00 beat GENinCode's score of -1.27 indicating that GENinCode is being referred to more favorably in the media.
GENinCode and Verici Dx both received 0 outperform votes by MarketBeat users.
GENinCode has higher revenue and earnings than Verici Dx. Verici Dx is trading at a lower price-to-earnings ratio than GENinCode, indicating that it is currently the more affordable of the two stocks.
GENinCode has a beta of 0.66, suggesting that its stock price is 34% less volatile than the S&P 500. Comparatively, Verici Dx has a beta of 1.53, suggesting that its stock price is 53% more volatile than the S&P 500.
Verici Dx's return on equity of -84.23% beat GENinCode's return on equity.
Summary
GENinCode beats Verici Dx on 7 of the 10 factors compared between the two stocks.
Get Verici Dx News Delivered to You Automatically
Sign up to receive the latest news and ratings for VRCI and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding VRCI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Verici Dx Competitors List
Related Companies and Tools
